Meeting
2011 ASCO Annual Meeting
The expression of GATA-3 and FOXA1 in breast cancer: The biomarkers of hormone sensitivity in luminal-type tumors.
Authors
Y. Hisamatsu
Department of Surgery and Science, Kyushu University, Fukuoka, Japan
Y. Hisamatsu , E. Tokunaga , S. Akiyoshi , S. Okada , N. Yamashita , E. Oki , M. Morita , Y. Kakeji , Y. Maehara
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - HER2/ER
Track
Breast Cancer
Sub Track
ER+
Citation
J Clin Oncol 29: 2011 (suppl; abstr 599)
Abstract #
599
Poster Bd #
9A
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Risk stratification in earl- stage luminal breast cancer patients treated with and without RT.
First Author: Charlotta Wadsten
Poster
2018 ASCO Annual Meeting
Long-term benefit from tamoxifen therapy for patients with Luminal A and Luminal B breast cancer: Retrospective analysis of the STO-3 trial.
First Author: Linda Lindström
Poster
2023 ASCO Annual Meeting
Endocrine therapy resistance (ETR) in hormone receptor-positive, HER2-negative metastatic breast cancer (HR+, HER2– mBC): Prevalence, biomarker characteristics, and outcomes.
First Author: Rinath Jeselsohn
